Lewis, D H, Mayberg, H S, Fischer, M E et al. · Radiology · 2001 · DOI
Quick Summary
Researchers used brain imaging scans to look for differences in blood flow to the brain in people with ME/CFS compared to their identical twins who don't have the disease. They found that the brain scans of people with ME/CFS looked very similar to those of their healthy twins, suggesting that ME/CFS may not cause detectable changes in how blood flows through the brain at rest.
Why It Matters
This study addresses whether ME/CFS produces detectable neuroimaging changes that could serve as biological markers of the disease. The use of identical twins as controls is particularly valuable because it eliminates genetic and many environmental confounders, making it a rigorous approach to distinguishing disease-specific from background variation. Understanding whether the brain shows structural or functional abnormalities in ME/CFS is important for validating it as an organic condition.
Observed Findings
No significant difference in the mean number of visually detected rCBF abnormalities between twins with CFS and healthy co-twins.
Automated quantification of rCBF images showed no distinctive pattern of abnormalities in the CFS-affected group.
Findings remained unchanged after statistical adjustment for fitness level, depression, and pre-imaging mood state.
Two blinded readers showed similar patterns on consensus reading, supporting reliability of the imaging interpretation.
Inferred Conclusions
Resting regional cerebral blood flow patterns do not provide evidence of a distinctive, detectable neuroimaging signature for CFS.
The similarity of rCBF between affected and unaffected identical twins suggests that any rCBF differences are not a primary or obligate feature of CFS.
Methodologically rigorous co-twin control designs are essential for reducing confounding and identifying disease-specific biomarkers.
Remaining Questions
Would dynamic or stress-induced cerebral blood flow measures (rather than resting scans) reveal differences between affected and unaffected twins?
Do other neuroimaging modalities (functional MRI, PET imaging, or structural measures) detect abnormalities that SPECT rCBF does not?
What This Study Does Not Prove
This negative finding does not prove that ME/CFS has no brain involvement—it only shows that resting rCBF patterns measured by SPECT do not reliably distinguish affected from unaffected twins. Other imaging modalities (fMRI, PET, structural MRI), challenge protocols (post-exertional malaise testing), or dynamic measures of cerebral blood flow might reveal differences not apparent on resting scans. The absence of visually detectable abnormalities does not rule out subtle metabolic or functional disturbances.
Tags
Symptom:Fatigue
Biomarker:Neuroimaging
Method Flag:Small SampleExploratory OnlyWeak Case Definition
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.